Skip to content

ABIOMED INC

CIK 0000815094

← back to feed
Revenue (TTM)
$1.05B
+327.7% YoY Q2 Oct 2022
Net Income (TTM)
$263.39M
+140.1% YoY Q2 Oct 2022
EPS Diluted (TTM)
$5.75
+140.3% YoY Q2 Oct 2022
Gross Margin
97.1%
Q2 Oct 2022
Operating Margin
23.7%
Q2 Oct 2022
Net Margin
25.0%
Q2 Oct 2022
Free Cash Flow (TTM)
$183.6M
Q2 Oct 2022
Cash
$182.34M
Q2 Oct 2022
Total Debt
—
Q2 Oct 2022
Shares Outstanding
45.09M sh
Q2 Oct 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings